- Investing Ideas
- U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
10
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
10 companies
Illumina
Market Cap: US$21.1b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$139.07
7D
9.6%
1Y
86.6%
Exelixis
Market Cap: US$11.2b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$44.42
7D
-1.1%
1Y
20.5%
ACADIA Pharmaceuticals
Market Cap: US$3.8b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$22.35
7D
-1.4%
1Y
53.7%
ADMA Biologics
Market Cap: US$2.4b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$10.25
7D
-6.0%
1Y
-55.7%
Aurinia Pharmaceuticals
Market Cap: US$2.0b
A biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.
AUPH
US$16.04
7D
0%
1Y
97.5%
Theravance Biopharma
Market Cap: US$870.7m
A biopharmaceutical company, develops and commercializes medicines in the United States.
TBPH
US$16.73
7D
-0.2%
1Y
65.8%
CorMedix
Market Cap: US$619.6m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.73
7D
2.1%
1Y
-30.7%
Abeona Therapeutics
Market Cap: US$338.5m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$5.83
7D
8.8%
1Y
1.3%
Compugen
Market Cap: US$249.6m
A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.
CGEN
US$2.72
7D
-0.4%
1Y
115.9%
Oramed Pharmaceuticals
Market Cap: US$159.0m
Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
ORMP
US$3.98
7D
-1.2%
1Y
78.5%